Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Declines By 42.6%

Coloplast A/S (OTCMKTS:CLPBY) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 60,700 shares, a decline of 42.6% from the January 31st total of 105,800 shares. Based on an average trading volume of 242,400 shares, the short-interest ratio is presently 0.3 days.

Coloplast A/S Stock Performance

Shares of Coloplast A/S stock traded up $0.19 on Tuesday, reaching $10.79. 164,336 shares of the company were exchanged, compared to its average volume of 189,308. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92. The company has a 50-day moving average of $11.11 and a 200 day moving average of $12.29. Coloplast A/S has a one year low of $10.54 and a one year high of $14.34.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, February 4th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. As a group, sell-side analysts expect that Coloplast A/S will post 0.31 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CLPBY has been the subject of several research reports. Hsbc Global Res raised shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research note on Monday, November 18th. UBS Group upgraded shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Sanford C. Bernstein upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.